#AstraZeneca's pivot toward the #US market has continued with the opening of a new R&D centre in the #biotechhotspot of Cambridge, Massachusetts, the centrepiece of a $1 billion #investment programme in the state.
@pharmaphorum.bsky.social@pharmaphorum.bsky.social